Oncology novel active substance (NAS) launches (cumulative) by region
2 of 3 regions drawn, 2005–2024 to 2020–2024; the rest are in the table
132
Global, 2020–2024
Oncology novel active substance (NAS) launches (cumulative) by region: 2 of 3 regions drawn, 2005–2024 to 2020–2024; the rest are in the table
Oncology novel active substance (NAS) launches (cumulative) by region: 2 of 3 regions drawn, 2005–2024 to 2020–2024; the rest are in the table. 2 regions on one axis: Global, China. 5 observations from 2005–2024 to 2020–2024, ranging from 37 to 282. Latest values: Global 132 (2020–2024); China 84 (2020–2024).
0
100
200
300
2005
2008
2011
2014
2017
2020
132
84
Global
China
Oncology novel active substance (NAS) launches (cumulative) by region: 2 of 3 regions drawn, 2005–2024 to 2020–2024; the rest are in the table
Oncology novel active substance (NAS) launches (cumulative) by region: 2 of 3 regions drawn, 2005–2024 to 2020–2024; the rest are in the table. 2 regions on one axis: Global, China. 5 observations from 2005–2024 to 2020–2024, ranging from 37 to 282. Latest values: Global 132 (2020–2024); China 84 (2020–2024).
0
100
200
300
2005
2008
2011
2014
2017
2020
132
84
Global
China
Oncology novel active substance (NAS) launches (cumulative) by region: 2 of 3 regions drawn, 2005–2024 to 2020–2024; the rest are in the table
Oncology novel active substance (NAS) launches (cumulative) by region: 2 of 3 regions drawn, 2005–2024 to 2020–2024; the rest are in the table. 2 regions on one axis: Global, China. 5 observations from 2005–2024 to 2020–2024, ranging from 37 to 282. Latest values: Global 132 (2020–2024); China 84 (2020–2024).
0
100
200
300
2005
2008
2011
2014
2017
2020
132
84
Global
China
View the underlying data
Oncology novel active substance (NAS) launches (cumulative) by region: 2 of 3 regions drawn, 2005–2024 to 2020–2024; the rest are in the table
Region
Period
Type
Value
Global
2020–2024
Actual
132
Global
2015–2019
Actual
79
Global
2005–2024
Actual
282
China
2020–2024
Actual
84
China
2015–2019
Actual
37
Chart:
StatOrigin
· Source: IQVIA ·
statorigin.org
CC BY 4.0